IBM, a leading name in the AI technology industry, recently exceeded market expectations with its Q2 earnings report, thanks primarily to increased client investments. This positive turn of events has led to a growth outlook revision for IBM’s software division and increased anticipation for a surge in annual growth revenue.
IBM’s recent successes have prompted plans to enhance its Watsonx platform, improving chatbot deployment and AI code optimization. In addition, IBM is offering open access to its AI model set, ‘Granite’, making this valuable resource freely accessible.
Following these developments, IBM’s shares climbed by 3% in after-hours trading, contributing to its impressive 12% growth this year. Q2 saw their software earnings rise by 7%, reaching $6.74 billion. This positive trend was not limited to software alone – the cloud and cognitive software segment recorded an increase of 6%, tipping the scale at $5.65 billion.
IBM’s “AI Book of Business,” an effective measure of the company’s success in the AI sector, grew to a remarkable $2 billion, with nearly $1 billion added just in Q2.
IBM’s Q2 earnings propel AI advancement
Investing analyst Tejas Dessai views IBM’s quick expansion into Generative AI as a strategic move to meet the growing demand for AI integration.
However, not all news was positive for IBM. The company had to lower its annual forecast for consulting revenues from 6-8% to low-single-digit percentages, citing decreased consulting earnings of $5.18 billion in Q2. This has been attributed to tightened discretionary spending and fewer immediate consulting projects, possibly due to increased interest rates and inflation.
Funding has been redirected to support long-term consulting projects, particularly those revolving around AI. However, their revenues are currently unaccounted for in IBM’s financial records. Despite this, IBM’s financial performance remains strong, with Q2 earnings surpassing projected figures. The company recorded total earnings of $15.77 billion, with a profit per share of $2.43, above the predicted $2.20.
